Last week was a busy one for makers of diabetes devices, with the FDA expanding the approval of Dublin-based Medtronic plc's Minimed 670G hybrid closed looped system, and San Diego's Tandem Diabetes Care Inc. reporting that it had received the agency's nod for the T:slim X2 insulin pump with Basal-IQ technology.